From the Web - Bedminster, New Jersey
NPS Reports Successful GATTEX(TM) Extension Study: BEDMINSTER, NJ, March 17 - NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) today reported positive top-line results from a 28-week blinded Phase 3-extension study of GATTEX(TM) (teduglutide) for short bowel syndrome (SBS) patients who are ...